Skip to main content

WidePoint Named Single Awardee of the $3.1 Billion DHS CWMS 3.0 Contract

FAIRFAX, Va., June 25, 2026 (GLOBE NEWSWIRE) — WidePoint Corporation (NYSE American: WYY), a leading provider of Secure Mobility Management solutions, today announced that it has been selected as the single awardee of the Department of Homeland Security’s (DHS) Cellular Wireless Managed Services (CWMS) 3.0 contract, a 10-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract consisting of a one-year base period and nine one-year option periods with a contract ceiling value of approximately $3.1 billion. “Securing DHS CWMS 3.0 as the single awardee is a major strategic milestone for WidePoint,” said Jin Kang, Chief Executive Officer of WidePoint. “This accomplishment solidifies the second catalyst I’ve discussed previously, the first being the contract with one of the three largest carriers in the United States. Progress...

Continue reading

WeRide GENESIS Named “Generative AI Platform of the Year,” Following ATTI Simulation Innovation Award

WeRide GENESIS received two major industry awards within days, including the 2026 ATTI Simulation Innovation Award and “Overall Gen-AI Solution of the Year” at the 2026 AI Breakthrough Awards. Physical AI world model enables large-scale autonomous driving simulation, training, and validation. Reduces autonomous driving data collection and annotation costs by more than 75%. Powers WRD 3.0, WeRide’s end-to-end ADAS solution, supporting global commercialization and deployment.GUANGZHOU, China, June 25, 2026 (GLOBE NEWSWIRE) — WeRide (NASDAQ: WRD; HKEX: 0800), a global autonomous driving technology company, announced today that its proprietary world model, WeRide GENESIS, has been named “Overall Gen-AI Solution of the Year” at the 2026 AI Breakthrough Awards. The recognition places WeRide alongside AMD, Qualcomm, and Dell Technologies,...

Continue reading

ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the evaluable 3 mg/kg and 6 mg/kg cohorts AX-0810 demonstrated up to 8-fold change (6 mg/kg) in total bile acids in serum, exceeding the 2-fold threshold identified by the Company as a meaningful indicator of NTCP modulation, along with concordant readouts of bile acid profile and TUDCA markers Favorable safety and tolerability profile observed with AX-0810 to date, with no serious adverse events or pruritus reported; pharmacokinetic findings to date support sustained target engagement, including a half-life of eight weeks The NTCP biomarker findings support advancement of next-generation candidate AX-0811 and future clinical studies in biliary atresiaLEIDEN, Netherlands & CAMBRIDGE, Mass., June...

Continue reading

Acuity Reports Fiscal 2026 Third-Quarter Results 

Solid Execution Delivers Sales Growth, EPS Improvement and Strong Cash FlowDelivered Net Sales of $1.2B, an Increase of 2% Compared to the Prior Year Delivered Operating Profit of $193M, Up 38% Compared to the Prior Year; Grew Adjusted Operating Profit to $224M, Up 1% Compared to the Prior Year Delivered Diluted EPS of $4.56, Up 46% Compared to the Prior Year; Grew Adjusted Diluted EPS to $5.31, Up 4% Compared to the Prior YearATLANTA, June 25, 2026 (GLOBE NEWSWIRE) — Acuity Inc. (NYSE: AYI), (“Acuity”), a market-leading industrial technology company, delivered net sales of $1.2 billion in the third quarter, ended May 31, 2026, an increase of $19.4 million, or 1.6 percent, compared to the prior year. “We demonstrated solid execution in our third quarter of fiscal 2026,” stated Neil Ashe, Chairman,...

Continue reading

Form 8.5 (EPT/RI) – Pharos Energy Plc

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code” 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Pharos Energy Plc(c)        Name of the party to the offer with which exempt principal trader is connected: Ratio Petroleum Energy LP(d)        Date dealing undertaken: 24 June 2026(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases and salesClass of relevant...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 24 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Ophævelse af suspension i forbindelse med overflytning af afdelinger til Investeringsforeningen IA Invest

I forlængelse af meddelelse fra Investeringsforeningen TOBA Investments den 22. juni 2026 vedrørende suspension som følge af overflytning bekræftes det hermed, at der igen kan stilles priser i afdelingerne herunder, og at afdelingerne har første handelsdag i regi af Investeringsforeningen IA Invest. Overflytningen af afdelingerne er gennemført i henhold til den fremlagte og vedtagne overflytningsplan.Afdeling ISIN-kode OMX Short nameTA Globale Aktier DK0061150398   IAITAGA  TA Globale Obligationer  DK0061150208   IAITAGO  Jyske Bank A/S varetager funktionen som market maker. Der henvises i øvrigt til det offentliggjorte prospekt for Investeringsforeningen IA Invest af 24. juni 2026. Eventuelle henvendelser vedrørende denne meddelelse kan rettes til undertegnede på telefon 3814 6600. Med venlig hilsenInvest Administration A/S Niels...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 24 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Share Buyback Transaction Details June 18 – June 24, 2026

PRESS RELEASE                                         Share Buyback Transaction Details June 18 – June 24, 2026 Alphen aan den Rijn – June 25, 2026 – Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 126,900 of its own ordinary shares in the period from June 18, 2026, up to and including June 24, 2026, for €7.3 million and at an average share price of €57.58. These repurchases are part of the share buyback program announced on February 25, 2026, under which we intend to repurchase shares for up to €500 million during 2026. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2026Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2026...

Continue reading

CaoCao and May Mobility Announce Strategic Partnership to Pioneer Robotaxi Expansion in Europe

HANGZHOU, China, June 25, 2026 (GLOBE NEWSWIRE) — Recently, CaoCao and May Mobility, a global autonomous vehicle technology company, entered into a strategic partnership to jointly explore the large-scale commercialization of Robotaxi services in international markets.Under the agreement, the two companies will conduct joint feasibility studies and commercial exploration of Robotaxi deployment, and advance pilot programs in key markets including Europe. The partnership will also deepen collaboration in market expansion, operational model innovation, and commercialization pathways, with the objective of progressing from pilot validation toward scalable deployment. CaoCao will leverage its strengths in ride-hailing operations, fleet management, vehicle support and maintenance, and large-scale commercial operations, serving as the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.